Probiotic Composition for COVID-19 Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for mild to moderate COVID-19 are inadequate, with existing therapies either ineffective or potentially worsening outcomes, and there is a need for therapies that can prevent progression to severe disease without adverse effects.
Innovation Solution
A probiotic composition comprising specific strains of Lactobacillus plantarum and Pediococcus acidilactici, which significantly increases antibody production, reduces viral load, and improves oxygen saturation, thereby enhancing immune response and reducing symptom duration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for mild to moderate COVID-19, then treatment options are limited, but the treatments are either ineffective or may worsen outcomes
Solution Approach 1:
The patent changes the parameter of immune system modulation by introducing specific probiotic strains (Lactobacillus plantarum CECT 30929, Lactobacillus plantarum CECT 7484, Lactobacillus plantarum CECT 7485, and Pediococcus acidilactici CECT 7483) that alter immune response parameters, leading to increased antibody production and viral clearance without adverse effects
Solution Approach 2:
The probiotic composition acts as an intermediary substance that mediates between the virus and the host immune system, enhancing immune response through specific bacterial strains that produce metabolites and modulate immune cell activity, thereby improving treatment effectiveness without direct harmful effects
2Reliability
If therapy duration is extended to achieve complete remission, then treatment effectiveness improves, but treatment time increases
Solution Approach 1:
The probiotic composition performs preliminary action by pre-modulating the immune system before viral replication reaches critical levels, enabling faster clearance of the virus and shorter symptom duration while achieving complete remission. The probiotics are administered early in the infection course to prime the immune response
Solution Approach 2:
The probiotic composition maintains continuous useful action throughout the infection course, with the bacterial strains continuously producing immune-modulating metabolites that sustain viral clearance and antibody production, leading to complete remission without requiring extended treatment time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The probiotic composition achieves complete remission of COVID-19 in a shorter duration, reduces viral load by 25 times, and significantly increases IgG and IgM antibody levels, while also improving blood oxygen saturation and reducing symptom duration, demonstrating a robust immune response and clinical efficacy.
Implementation Method 1
the probiotic composition achieves complete remission of COVID-19 in a shorter duration, reduces viral load by 25 times, and significantly increases IgG and IgM antibody levels, while also improving blood oxygen saturation and reducing symptom duration, demonstrating a robust immune response and clinical efficacy
Implementation Method 2
reduces viral load by 25 times
Implementation Method 3
improving blood oxygen saturation
Data Source
AI summary
A probiotic composition comprising Lactobacillus plantarum CECT 30292, Lactobacillus plantarum CECT 7484, Lactobacillus plantarum CECT 7485, and Pediococcus acidilactici CECT 7483 is provided. The probiotic composition is useful in treating, preventing, or ameliorating CO VID-19, and other infectious diseases. It is also useful in enhancing the immune response.